Immediate Hypersensitivity, Asthma, and Allergic Responses (HYP)

Airway Hypersensitivity and Asthma

Immediate and Delayed Hypersensitivity

(180) From Mouse to Clinic: Non-Invasive Swab-Based Profiling of Inflammatory and Barrier Markers in Atopic Dermatitis

(181) Investigating interferon lambda (IFN-λ) as a novel anti-inflammatory modulator of the skin barrier-immune-microbiome axis in atopic dermatitis.

(182) Humoral responses in skin inflammation resulted from altered expression of epidermal Blimp-1

(183) A secondary Bile Acid regulates IgE+ germinal center B cell differentiation and IgE-mediated immune homeostasis

(184) Feasibility and Immunological Impact of Reusing Wild-Type C57BL/6 Mice in Systemic and Cutaneous Anaphylaxis Models

(185) Serum factor regulation of mast cell desensitization following combined immunotherapy

(186) Filaggrin-deficiency drives immunopathogenic IL-18 response during in the initiation of atopic dermatitis

(187) Discovery, characterization and preclinical evaluation a novel engineered Fc-fused IgE cleaving enzyme for the treatment of IgE-mediated diseases

(188) IFNAR and STING signaling restrict proliferation of hapten- primed CD8 T cells producing IFN in response to skin sensitization

(189) Optimization and Clinical Correlation of the Basophil Activation Test for Drug-Induced Anaphylaxis Diagnosis in Bolivia

(190) Evaluation of intrinsic allergenicity of amaranth seed, pinto bean and kidney bean using an adjuvant free mouse model of food allergy.

(191) Creation of the first gluten allergenicity map using diploid, tetraploid, and hexaploid wheats in a mouse model

(191) LPS-HDM-Induced Asthma Model: A Translational Platform for Neutrophilic Asthma and Glucocorticoid-Resistant Inflammation

(192) Liver-targeted allergen immunotherapy rapidly and safely induces antigen-specific tolerance to treat allergic diseases

(192) Milk Allergen-Induced Eosinophil Activation in Eosinophilic Esophagitis: The IgG4 Pathway

(193) EPS-3903 Is a Potent and Selective Oral STAT6 Inhibitor that Blocks Th2 Inflammation in an Ovalbumin Asthma Mouse Model

(193) Multi-Mechanistic Approaches to Disarming IgE-Mediated Allergic Diseases

(194) Discovery and Characterization of a Potent and Selective Oral Inhibitor of STAT6 for the Treatment of Allergic Diseases

(194) ZL-1503: A Bispecific Antibody Targeting IL-13 and IL-31Rα Sustains Suppression of Pruritus and Atopic Disease in Non-Human Primates

(195) Chronic lung exposure to Saccharopolyspora rectivirgula leads to a pulmonary fibrotic pattern in mice

(195) Epigenetic Regulation of FosB in Mast Cells

(196) Kolliphor EL Alters IgE-Mediated Immune Functions

(196) Respiratory bacterial experience protects from allergic airway eosinophilia

(197) B cell-intrinsic CCR6 expression is required for IgE production in a murine model of galactose-alpha-1,3-galactose syndrome

(198) Molecular characterization of the IgE serological repertoire in pediatric peanut allergy

(198) Regulation of house dust mite-induced asthma by a B cell-expressed dual protein phosphatase

(199) ATP Mediated Mast Cell Activation is Female Dominant

(199) Pharmacological Evaluation of TSLP Dependency in Preclinical Asthma Models

(200) A novel engineered cytokine immunotherapy reduces clinical features of disease in a mouse model of steroid-resistant asthma

(200) Necroptosis in SJS/TEN: RIPK1 and RIPK3 Expression and Implications for Disease Pathogenesis

(201) Ozureprubart, a next-gen anti-IgE antibody, inhibits IgE binding to FcεRI, dissociates FcεRI-bound IgE, and reduces FcεRI expression on basophils

(201) The role of Glutamine metabolism in conventional Dendritic Cells and the downstream polarization of CD4+ T-cells

(203) VEGF-C enhances BALT and skews IgE responses towards a pathogenic, anaphylactic profile in mouse models of allergic asthma

(204) Investigation of the Impact of BECC-Derived Adjuvants in Allergen-Specific Immunotherapy

(205) Pharmacological activation of LANCL2 provides immunometabolic protection from disease and lung pathology in mouse models of asthma

(206) Pulmonary immunomodulation by nitroalkenes: implications for asthma-associated inflammation

(208) Nicotine Reprograms Macrophage Autophagy to Drive Pro-Inflammatory Lung Immunity

(209) The Inhalation of Deoxynivalenol in a Murine Model of Allergic Fungal Asthma

(210) Multifactorial Immune Response Between Male and Female BALB/cJ and C57BL/6J Mice Exposed to Aspergillus fumigatus

(211) Association Between Obesity and Asthma Severity: Analysis of NHANES Data 2021–2023

(212) Targeting IL-33 and TSLP in Asthma: Efficacy Assessment in Humanized Mouse Models

(214) Immunologic Drivers of Fruit-Specific Allergy Patterns in Latex–Fruit Syndrome

(215) JAM-A deficiency alters dendritic cell phenotype in a mouse model of food allergy

Late-breaking: Immediate Hypersensitivity, Asthma, and Allergic Responses